Get started
Author

Julia Dreisbach

In Vivo Dearomatization of the Potent Antituberculosis Agent BTZ043 via Meisenheimer Complex Formation
2017 · Florian Kloss, Viktor Krchnak, et al. · Angewandte Chemie International Edition · 63
Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043–02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial
2025 · Norbert Heinrich, Veronique de Jager, et al. · The Lancet Microbe · 30
PDF
The clinical-stage drug BTZ-043 accumulates in murine tuberculosis lesions and efficiently acts against Mycobacterium tuberculosis
2025 · Andreas Römpp, Axel Treu, et al. · Nature Communications · 23
PDF
Pharmacokinetics and Efficacy of the Benzothiazinone BTZ-043 against Tuberculous Mycobacteria inside Granulomas in the Guinea Pig Model
2023 · Emmelie Eckhardt, Yan Li, et al. · Antimicrobial Agents and Chemotherapy · 15
PDF
Effect of seven anti-tuberculosis treatment regimens on sputum microbiome: a retrospective analysis of the HIGHRIF study 2 and PanACEA MAMS-TB clinical trials
2023 · Emmanuel Musisi, Adam Wyness, et al. · The Lancet Microbe · 11
PDF
First-in-human study of the benzothiazinone and DprE1 inhibitor BTZ-043, a novel drug candidate for the treatment of Tuberculosis
2025 · Wandini Lutchmun, Norbert Heinrich, et al. · JAC-Antimicrobial Resistance · 6
Cardiac safety of bedaquiline, delamanid and moxifloxacin co-administered with or without varying doses of sutezolid or delpazolid for the treatment of drug-susceptible TB
2025 · Simon E Koele, Krista Stoycheva, et al. · Journal of Antimicrobial Chemotherapy · 5
PDF
BTZ-043 Shows Good Safety and Strong Bactericidal Activity in a Combined Phase1b/2a Study in Tuberculosis Patients
2023 · Norbert Heinrich, Veronique De Jager, et al. · SSRN Electronic Journal · 5
Population pharmacokinetics and exposure–response relationship of the antituberculosis drug BTZ-043
2025 · Simon E Koele, Norbert Heinrich, et al. · Journal of Antimicrobial Chemotherapy · 4
In‐vivo‐Dearomatisierung des potenten Antituberkulose‐Wirkstoffs BTZ043 durch Bildung eines Meisenheimer‐Komplexes
2017 · Florian Kloss, Viktor Krchnak, et al. · Angewandte Chemie · 3
Translational Modeling of BTZ-043 to Predict Phase 2A Efficacy and Evaluate Drug-Drug Interactions With Bedaquiline, Pretomanid, and Linezolid in Murine Models
2025 · Bernard Ngara, Lorenzo Flori, et al. · The Journal of Infectious Diseases · 2
Innentitelbild: In‐vivo‐Dearomatisierung des potenten Antituberkulose‐Wirkstoffs BTZ043 durch Bildung eines Meisenheimer‐Komplexes (Angew. Chem. 8/2017)
2017 · Florian Kloss, Viktor Krchnak, et al. · Angewandte Chemie · 2
PDF
Modeling Treatment Response in Tuberculosis Early Bactericidal Activity Trials
2026 · Mairi C. W. McClean, Simon E. Koele, et al. · CPT Pharmacometrics & Systems Pharmacology
Modelling treatment response in tuberculosis early bactericidal activity trials
2026 · Mairi CW McClean, Simon E Koele, et al. · medRxiv
Low-level BTZ-043 resistance in Mycobacterium tuberculosis and cross-resistance to bedaquiline and clofazimine
2025 · A. Ghodousi, I. Iannucci, et al. · IJTLD OPEN
Low-level BTZ-043 resistance in Mycobacterium tuberculosis and cross-resistance to bedaquiline and clofazimine
2025 · Ghodousi, Arash, Iannucci, I., et al. · Fraunhofer-Publica (Fraunhofer-Gesellschaft)
Untersuchungen im Meerschweinchen (Cavia porcellus) zur Wirksamkeit des Benzothiazinons BTZ-043 gegen Mycobacterium tuberculosis
2023 · J. Schinköthe, E. Eckhardt, et al. · Tierärztliche Praxis Ausgabe K Kleintiere / Heimtiere
Untersuchungen im Meerschweinchen (Cavia porcellus) zur Wirksamkeit des Benzothiazinons BTZ-043 gegen Mycobacterium tuberculosis
2023 · J Schinköthe, E Eckhardt, et al. · Tierärztliche Praxis Ausgabe G Großtiere / Nutztiere
Collaborative project: TTU 02.901 - BTZ043 - a novel TB drug (Klinikum der Universität München) : subproject: TTU 02.901 - BTZ043 - a novel TB drug (Klinikum der Universität München), TTU 02.901 - BTZ043 - a novel TB drug (Forschungszentrum Borstel), TTU 02.901 - BTZ043 - a novel TB drug (Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e.V. Hans-Knöll-Institut)
2018 · Hoelscher, Michael, Dreisbach, Julia, et al. · TIB Hannover
Inside Cover: In Vivo Dearomatization of the Potent Antituberculosis Agent BTZ043 via Meisenheimer Complex Formation (Angew. Chem. Int. Ed. 8/2017)
2017 · Florian Kloss, Viktor Krchnak, et al. · Angewandte Chemie International Edition
PDF
Klonierung, Expression und funktionelle Analyse von Hühner-Interleukin-12
2005 · Dreisbach, Julia · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München)
PDF
Works count: 24
Citation count: 169
H-index: 6
I10-index: 5
Year
Topic
Type